NCT03388619 2026-02-23
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
156 trialsNCT03707574 2026-02-04
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Completed
NCT04465214 2025-12-15
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT03253744 2025-10-08
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02769962 2025-07-28
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02430480 2025-07-16
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00923104 2025-07-08
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
National Institutes of Health Clinical Center (CC)
Completed
NCT00026754 2025-04-18
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Completed
NCT03436745 2025-02-11
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02649855 2024-08-06
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00341939 2024-06-13
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Institutes of Health Clinical Center (CC)
Completed
NCT02933255 2024-05-31
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00020046 2023-10-31
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00942331 2023-10-16
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01867333 2023-09-26
Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001503 2023-06-18
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
National Institutes of Health Clinical Center (CC)
Completed
NCT02649439 2022-11-14
Prostvac in Patients With Biochemically Recurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00972309 2022-10-12
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01377753 2022-02-01
MR Image Guided Therapy in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03481816 2021-05-19
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02179515 2021-01-26
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00340600 2020-11-16
Continuation of Follow-up of DES-Exposed Cohorts
National Institutes of Health Clinical Center (CC)
Completed
NCT01576172 2020-11-12
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01875250 2020-09-16
Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00064129 2020-07-30
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01867424 2020-07-08
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02948413 2020-05-26
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
National Institutes of Health Clinical Center (CC)
Completed
NCT00339534 2020-05-20
Survey of Prostate Cancer in Accra, Ghana
National Institutes of Health Clinical Center (CC)
Completed
NCT00339664 2020-03-30
Analyses of Human Samples Collected in Clinical Trials
National Institutes of Health Clinical Center (CC)
Completed
NCT00001469 2020-03-16
Genetic Analysis of Hereditary Prostate Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT02095145 2020-02-05
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance
National Cancer Institute (NCI)
Phase 2 Completed
NCT00113984 2019-12-16
Vaccine and Antibody Treatment of Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00032825 2019-11-21
Ketoconazole Plus Docetaxel to Treat Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01176526 2019-11-13
The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis
National Institutes of Health Clinical Center (CC)
Completed
NCT01683994 2019-11-08
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02141490 2019-09-06
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00214422 2019-07-19
Intensity Modulated Radiation Therapy for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02190279 2019-04-23
18F-DCFBC PET/CT in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT01553188 2019-03-05
AMG 386 and Abiraterone for Advanced Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02153918 2018-10-12
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00942578 2018-10-11
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01260688 2018-08-08
Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel
National Cancer Institute (NCI)
Phase 2 Completed
NCT00039624 2018-08-02
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00342784 2018-08-01
Identification of Prostate Cancer Genes
National Institutes of Health Clinical Center (CC)
Completed
NCT01296139 2018-07-05
Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00892736 2018-06-29
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed
NCT00090545 2018-06-14
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00082147 2018-06-13
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase NA Completed